Cardiovascular disease remains a leading cause of death worldwide, and Brunei is no exception. Brunei recorded 669 cardiovascular deaths last year compared to 416 cases in 2021, making cardiovascular disease the second major cause of death in the Sultanate, said Cardiac Society Brunei Darussalam (CSBD) President Pengiran Dr Md Nadzir bin Pengiran Mohd Juanda. He […]
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the.
PALO ALTO, Calif., Oct. 11, 2023 /PRNewswire/ Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high.
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months
Hosts are joined by Marat Fudim, MD, MHS, of Duke, to discuss the REBALANCE-HF trial, which examined endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction.